✦ LIBER ✦

Management of dyslipidemia in people with type 2 diabetes mellitus

✍ Scribed by Fredrick L. Dunn

Publisher: Springer
Year: 2010
Tongue: English
Weight: 200 KB
Volume: 11
Category: Article
ISSN: 1389-9155
DOI: 10.1007/s11154-010-9132-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gait characteristics in people with type

Gait characteristics in people with type 2 diabetes mellitus

✍ Jerrold Petrofsky; Scott Lee; Salameh Bweir 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 322 KB

Management of type 2 diabetes mellitus a

Management of type 2 diabetes mellitus associated with pituitary gigantism

✍ Omar Ali; Swati Banerjee; Daniel F. Kelly; Phillip D. K. Lee 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 247 KB

Managing blood pressure in type 2 diabet

Managing blood pressure in type 2 diabetes mellitus

✍ Padfield, Paul L. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 2 views

Managing blood pressure in type 2 diabet

Managing blood pressure in type 2 diabetes mellitus

✍ McKnight, J.A. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

Pravastatin compared to bezafibrate in t

Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus

✍ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background Both HMG-CoA reductase inhibitors and ®bric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg beza®brate, a ®bric acid deriva

Considerations on blood glucose manageme

Considerations on blood glucose management in Type 2 diabetes mellitus

✍ Professor Philip Home; Antonio Chacra; Juliana Chan; Alistair Emslie-Smith; Lea 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views